NeoSurgical is an emerging, award-winning global medical device company focused on providing technical innovation to the surgical devices industry, particularly for those surgeons conducting laparoscopic and minimally invasive surgery (MIS). The companies neoClose® Trocar Port Closure System received FDA approval in 2013 and brings a simple, intuitive, and reliable solution to assist the surgeon in closing port site defects following laparoscopic abdominal surgery. This device is positioned to change the standard of care in port site closure while helping minimize port site pain and herniation, two potential clinical consequences of surgery that create significant issues for both patients and surgeons.